| Literature DB >> 21914208 |
Larry Sawers1, Alan G Isaac, Eileen Stillwaggon.
Abstract
BACKGROUND: The concurrency hypothesis asserts that high prevalence of overlapping sexual partnerships explains extraordinarily high HIV levels in sub-Saharan Africa. Earlier simulation models show that the network effect of concurrency can increase HIV incidence, but those models do not account for the coital dilution effect (non-primary partnerships have lower coital frequency than primary partnerships).Entities:
Mesh:
Year: 2011 PMID: 21914208 PMCID: PMC3182950 DOI: 10.1186/1758-2652-14-44
Source DB: PubMed Journal: J Int AIDS Soc ISSN: 1758-2652 Impact factor: 5.396
Parameters and parameter values used in simulationsa
| Number of males in population | 10,000 |
| Number of females in population | 10,000 |
| Partnership formation rate | 0.01 |
| Partnership dissolution probability | 0.005/day |
| Mean partnership duration | 200 days |
| Primary partnership transmission probability | |
| during primary infection | 0.00732/day |
| during asymptomatic infection | 0.00029/day |
| during symptomatic infection | 0.00208/day |
| during severe AIDS infection | 0.0/day |
| Non-primary partnership transmission probability | |
| in focal simulation | 75% less than in primary partnerships |
| in sensitivity analysis | 55%, 35%, 25%, 15%, 0% smaller |
| Duration of primary infection | 88 days |
| Duration of asymptomatic infection | 3054 days |
| Duration of symptomatic infection | 274 days |
| Duration between infection and death | 3723 days |
| Number of male seed infections | 100 (1%) |
| Number of female seed infections | 100 (1%) |
aThis table is adapted from Eaton et al, Table One [9] by specifying different transmission probabilities for primary and non-primary partnerships. Primary partnership transmission probabilities are taken directly from [9].
HIV prevalence at different degrees of concurrency with 75%, 55%, 35%, 25%, 15%, and 0% coital dilution at 0 to 250 years
| Time | ||||||
|---|---|---|---|---|---|---|
| 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | |
| 0.81% | 0.72% | 0.64% | 0.58% | 0.52% | 0.51% | |
| 0.56% | 0.41% | 0.29% | 0.23% | 0.17% | 0.16% | |
| 0.29% | 0.15% | 0.08% | 0.04% | 0.03% | 0.02% | |
| 0.09% | 0.02% | 0.01% | 0.00% | 0.00% | 0.00% | |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | |
| 0.81% | 0.75% | 0.71% | 0.70% | 0.68% | 0.70% | |
| 0.57% | 0.45% | 0.40% | 0.36% | 0.35% | 0.37% | |
| 0.30% | 0.21% | 0.16% | 0.13% | 0.12% | 0.14% | |
| 0.09% | 0.04% | 0.03% | 0.01% | 0.01% | 0.02% | |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | |
| 0.81% | 0.80% | 0.81% | 0.82% | 0.85% | 0.92% | |
| 0.56% | 0.55% | 0.55% | 0.59% | 0.64% | 0.80% | |
| 0.30% | 0.29% | 0.28% | 0.33% | 0.41% | 0.64% | |
| 0.09% | 0.07% | 0.07% | 0.10% | 0.18% | 0.38% | |
| 0.00% | 0.00% | 0.00% | 0.01% | 0.02% | 0.08% | |
| 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | ||
| 0.81% | 0.81% | 0.84% | 0.89% | 0.97% | ||
| 0.56% | 0.57% | 0.62% | 0.71% | 0.86% | ||
| 0.29% | 0.32% | 0.35% | 0.51% | 0.71% | ||
| 0.09% | 0.10% | 0.14% | 0.25% | 0.54% | ||
| 0.00% | 0.00% | 0.01% | 0.03% | 0.20% | ||
| 1.00% | 1.00% | 1.00% | 1.00% | |||
| 0.81% | 0.86% | 0.88% | 0.96% | |||
| 0.56% | 0.63% | 0.70% | 0.89% | |||
| 0.29% | 0.38% | 0.51% | 0.75% | |||
| 0.09% | 0.13% | 0.25% | 0.58% | |||
| 0.00% | 0.01% | 0.03% | 0.21% | |||
| 1.00% | 1.00% | 1.00% | ||||
| 0.81% | 0.87% | 0.96% | ||||
| 0.57% | 0.67% | 0.86% | ||||
| 0.30% | 0.42% | 0.73% | ||||
| 0.10% | 0.18% | 0.52% | ||||
| 0.00% | .02% | 0.19% | ||||
Figure 1HIV prevalence at different levels of concurrency from 0 to 250 years with coital dilution of 75%.
Figure 2HIV prevalence at different levels of concurrency from 0 to 250 years with no coital dilution.